See how others have used p-ATF-2 (Thr 71): sc-7982 antibody and or p-ATF-2 (Thr 71) antibody conjugates.
Sangerman J, et al. 2006. Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. Blood. 108(10): 3590-3599. View PubMed Entry
Bordin, S. et al. 2003. Cutting edge: proliferating fibroblasts respond to collagenous C1q with phosphorylation of p38 mitogen-activated protein kinase and apoptotic features. J. Immunology. 170: 667-671. View PubMed Entry
Wen-Sheng, W. et al. 2003. ERK signaling pathway is involved in
p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene. 22: 955-963. View PubMed Entry
p-ATF-2 (Thr 71)-R: sc-7982-R. Western blot analysis of ATF-2 phosphorylation in anisomycin-treated NIH/3T3 cells. Antibody was preincubated with either the cognate phosphopeptide (A) or non-phosphorylated peptide (B).
Western blot analysis of human recombinant ATF-2 untreated fusion protein (A,C) or phosphorylated by human recombinant JNK1 (B,D). Antibodies tested include ATF-2 (N-96): sc-6233 (A,B) and p-ATF-2 (Thr 71)-R: sc-7982-R (C,D).
p-ATF-2 (Thr 71)-R: sc-7982-R. Western blot analysis of ATF-2 phosphorylation in anisomycin-treated NIH/3T3 cells. Antibody was preincubated with either the cognate phosphopeptide (A) or non-phosphorylated peptide (B).
Western blot analysis of human recombinant ATF-2 untreated fusion protein (A,C) or phosphorylated by human recombinant JNK1 (B,D). Antibodies tested include ATF-2 (N-96): sc-6233 (A,B) and p-ATF-2 (Thr 71)-R: sc-7982-R (C,D).
